Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Tenaya Therapeutics Inc (TNYA)

Tenaya Therapeutics Inc (TNYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tenaya Therapeutics Inc 171 OYSTER POINT BOULEVARD SUITE 500 SOUTH SAN FRANCISCO CA 94080 USA

www.tenayatherapeutics.com Employees: 140 P: 650-825-6990

Description:

Tenaya Therapeutics Inc. is a biotechnology company. It discovers, develop and deliver curative therapies which address the underlying causes of heart disease. The company's product platform consist Gene Therapy, Cellular Regeneration and Precision Medicine. Tenaya Therapeutics Inc. is based in SOUTH SAN FRANCISCO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 188,546
Enterprise Value, $K 142,866
Shares Outstanding, K 79,221
Annual Sales, $ 0 K
Annual Net Income, $ -124,080 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -25,630 K
EBIT, $ -122,740 K
EBITDA, $ -113,740 K
60-Month Beta 2.34
% of Insider Shareholders 32.76%
% of Institutional Shareholders 90.54%
Float, K 53,268
% Float 67.24%
Short Volume Ratio 0.31

Growth:

1-Year Return 34.46%
3-Year Return -87.55%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.30 on 11/06/24
Next Earnings Date 11/13/24
Earnings Per Share ttm -1.44
EPS Growth vs. Prev Qtr 11.76%
EPS Growth vs. Prev Year 23.08%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

TNYA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -86.16%
Return-on-Assets % -71.14%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.51
Book Value/Share 1.43
Interest Coverage -2.74
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar